Sharon L. Salmon

Sharon L. Salmon

Auto-generated profile, based on publicly available information

Sharon L. Salmon

Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2019 in Vaccines
Verified
Journal Article
Open access
PDF file
SRSean Roberts
Sean Roberts
CWClare M. Williams
Clare M. Williams
SSSharon L. Salmon
Sharon L. Salmon
JBJesse Bonin
Jesse Bonin
MDMetzger Dennis
Metzger Dennis
YFYoichi Furuya
Yoichi Furuya
Secondary bacterial pneumonia is responsible for significant morbidity and mortality during seasonal and pandemic influenza. Due to the unpredictability of influenza A virus evolution and the time-consuming process of manufacturing strain-specific influenza vaccines, recent efforts have been focused on developing anti-Streptococcus pneumoniae immunity to prevent influenza-related illness and death. Bacterial vaccination to prevent viral-bacterial synergistic interaction during co-infection is a promising concept that needs further investigation. Here, we show that immunization with pneumococcal surface protein A (PspA) fully protects mice against low-dose, but not high-dose, secondary bacterial challenge using a murine model of influenza A virus-S. pneumoniae co-infection. We further show that immunization with PspA is more broadly protective than the pneumococcal conjugate vaccine (Prevnar). These results demonstrate that PspA is a promising vaccine target that can provide protection against a physiologically relevant dose of S. pneumoniae following influenza infection.